Marta García1, Jesús González de Buitrago2, Mireia Jiménez-Rosés3, Leonardo Pardo3, Patricia M Hinkle4, José C Moreno1. 1. Thyroid Molecular Laboratory, Institute for Medical and Molecular Genetics, La Paz University Hospital, Autonomous University of Madrid, 28046 Madrid, Spain. 2. Department of Pediatrics, San Pedro de Alcántara Hospital, 10003 Cáceres, Spain. 3. Computational Medicine Laboratory, Biostatistics Unit, Autonomous University of Barcelona, 08193 Barcelona, Spain. 4. Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York 14642.
Abstract
Context: Central congenital hypothyroidism (CCH) is an underdiagnosed disorder characterized by deficient production and bioactivity of thyroid-stimulating hormone (TSH) leading to low thyroid hormone synthesis. Thyrotropin-releasing hormone (TRH) receptor (TRHR) defects are rare recessive disorders usually associated with incidentally identified CCH and short stature in childhood. Objectives: Clinical and genetic characterization of a consanguineous family of Roma origin with central hypothyroidism and identification of underlying molecular mechanisms. Design: All family members were phenotyped with thyroid hormone profiles, pituitary magnetic resonance imaging, TRH tests, and dynamic tests for other pituitary hormones. Candidate TRH, TRHR, TSHB, and IGSF1 genes were screened for mutations. A mutant TRHR was characterized in vitro and by molecular modeling. Results: A homozygous missense mutation in TRHR (c.392T > C; p.I131T) was identified in an 8-year-old boy with moderate hypothyroidism (TSH: 2.61 mIU/L, Normal: 0.27 to 4.2; free thyroxine: 9.52 pmol/L, Normal: 10.9 to 25.7) who was overweight (body mass index: 20.4 kg/m2, p91) but had normal stature (122 cm; -0.58 standard deviation). His mother, two brothers, and grandmother were heterozygous for the mutation with isolated hyperthyrotropinemia (TSH: 4.3 to 8 mIU/L). The I131T mutation, in TRHR intracellular loop 2, decreases TRH affinity and increases the half-maximal effective concentration for signaling. Modeling of TRHR-Gq complexes predicts that the mutation disrupts the interaction between receptor and a hydrophobic pocket formed by Gq. Conclusions: A unique missense TRHR defect identified in a consanguineous family is associated with central hypothyroidism in homozygotes and hyperthyrotropinemia in heterozygotes, suggesting compensatory elevation of TSH with reduced biopotency. The I131T mutation decreases TRH binding and TRHR-Gq coupling and signaling.
Context: Central congenital hypothyroidism (CCH) is an underdiagnosed disorder characterized by deficient production and bioactivity of thyroid-stimulating hormone (TSH) leading to low thyroid hormone synthesis. Thyrotropin-releasing hormone (TRH) receptor (TRHR) defects are rare recessive disorders usually associated with incidentally identified CCH and short stature in childhood. Objectives: Clinical and genetic characterization of a consanguineous family of Roma origin with central hypothyroidism and identification of underlying molecular mechanisms. Design: All family members were phenotyped with thyroid hormone profiles, pituitary magnetic resonance imaging, TRH tests, and dynamic tests for other pituitary hormones. Candidate TRH, TRHR, TSHB, and IGSF1 genes were screened for mutations. A mutant TRHR was characterized in vitro and by molecular modeling. Results: A homozygous missense mutation in TRHR (c.392T > C; p.I131T) was identified in an 8-year-old boy with moderate hypothyroidism (TSH: 2.61 mIU/L, Normal: 0.27 to 4.2; free thyroxine: 9.52 pmol/L, Normal: 10.9 to 25.7) who was overweight (body mass index: 20.4 kg/m2, p91) but had normal stature (122 cm; -0.58 standard deviation). His mother, two brothers, and grandmother were heterozygous for the mutation with isolated hyperthyrotropinemia (TSH: 4.3 to 8 mIU/L). The I131T mutation, in TRHR intracellular loop 2, decreases TRH affinity and increases the half-maximal effective concentration for signaling. Modeling of TRHR-Gq complexes predicts that the mutation disrupts the interaction between receptor and a hydrophobic pocket formed by Gq. Conclusions: A unique missense TRHR defect identified in a consanguineous family is associated with central hypothyroidism in homozygotes and hyperthyrotropinemia in heterozygotes, suggesting compensatory elevation of TSH with reduced biopotency. The I131T mutation decreases TRH binding and TRHR-Gq coupling and signaling.
Authors: Roland Rabeler; Jens Mittag; Lars Geffers; Ulrich Rüther; Michael Leitges; Albert F Parlow; Theo J Visser; Karl Bauer Journal: Mol Endocrinol Date: 2004-02-26
Authors: Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka Journal: Nature Date: 2011-07-19 Impact factor: 49.962
Authors: Sjoerd D Joustra; Ferdinand Roelfsema; A S Paul van Trotsenburg; Harald J Schneider; Robert P Kosilek; Herman M Kroon; John G Logan; Natalie C Butterfield; Xiang Zhou; Chirine Toufaily; Beata Bak; Marc-Olivier Turgeon; Emilie Brûlé; Frederik J Steyn; Mark Gurnell; Olympia Koulouri; Paul Le Tissier; Pierre Fontanaud; J H Duncan Bassett; Graham R Williams; Wilma Oostdijk; Jan M Wit; Alberto M Pereira; Nienke R Biermasz; Daniel J Bernard; Nadia Schoenmakers Journal: J Clin Endocrinol Metab Date: 2020-03-01 Impact factor: 5.958
Authors: Peter Lauffer; Nitash Zwaveling-Soonawala; Jolanda C Naafs; Anita Boelen; A S Paul van Trotsenburg Journal: Front Endocrinol (Lausanne) Date: 2021-09-09 Impact factor: 5.555
Authors: Luca Persani; Georg Brabant; Mehul Dattani; Marco Bonomi; Ulla Feldt-Rasmussen; Eric Fliers; Annette Gruters; Dominique Maiter; Nadia Schoenmakers; A S Paul van Trotsenburg Journal: Eur Thyroid J Date: 2018-07-19